DURECT Corp
General ticker "DRRX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $26.8M
DURECT Corp follows the US Stock Market performance with the rate: 30.6%.
Estimated limits based on current volatility of 6.3%: low 0.87$, high 0.99$
Factors to consider:
- US accounted for 28.2% of revenue in the fiscal year ended 2022-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.60$, 1.98$]
- 2024-12-30 to 2025-12-30 estimated range: [0.75$, 2.07$]
Financial Metrics affecting the DRRX estimates:
- Negative: Non-GAAP EPS, $ of -1.65 <= 0.10
- Negative: Operating profit margin, % of -81.19 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -68.66 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: 0 < Interest expense per share, $ of 0.11
- Negative: Inventory ratio change, % of 10.73 > 1.08
Short-term DRRX quotes
Long-term DRRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $13.98MM | $19.28MM | $8.55MM |
| Operating Expenses | $48.25MM | $54.37MM | $45.43MM |
| Operating Income | $-34.27MM | $-35.08MM | $-36.88MM |
| Non-Operating Income | $-1.99MM | $-0.25MM | $9.26MM |
| Interest Expense | $2.15MM | $2.40MM | $2.79MM |
| R&D Expense | $31.85MM | $36.86MM | $29.35MM |
| Income(Loss) | $-36.27MM | $-35.33MM | $-27.62MM |
| Profit(Loss) | $-36.27MM | $-35.33MM | $-27.62MM |
| Stockholders Equity | $57.78MM | $24.98MM | $14.78MM |
| Inventory | $1.87MM | $2.11MM | $2.22MM |
| Assets | $91.99MM | $60.10MM | $45.19MM |
| Operating Cash Flow | $-37.31MM | $-26.28MM | $-34.41MM |
| Capital expenditure | $0.19MM | $0.11MM | $0.05MM |
| Investing Cash Flow | $15.31MM | $19.84MM | $-1.17MM |
| Financing Cash Flow | $50.53MM | $0.08MM | $20.50MM |
| Earnings Per Share* | $-1.69 | $-1.56 | $-1.22 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.